* USDA * Certified Organic

Clinical Articles

Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis

Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis Posted on July 22, 2022 Cannabinoid receptor [CB] activation can attenuate inflammatory bowel disease [IBD] in experimental models and human cohorts. However, the roles of the microbiome, metabolome, and the respective contributions of haematopoietic and non-haematopoietic cells in the anti-colitic effects of cannabinoids have …

Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis Read More »